All In MedTech

Device Trial Radar · NCT03913689

StimRouter Registry Clinical Protocol

A Prospective, Open-label, Long-term, Multi-center, Registry to Assess the Safety and Efficacy of the Bioness StimRouter Neuromodulation System in Subjects With Chronic Pain of Peripheral Nerve Origin

Last checked: Nov 20, 2026Latest source record: May 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

62

Actual

Start

Jun 26, 2019

Primary completion

Mar 30, 2024

Study completion Jun 30, 2024

Sponsor

Lead sponsor
Bioness IncNot on our public-company list
Sponsor type
Industry
First posted
Apr 12, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This Registry study will prospectively evaluate the long-term effectiveness, safety, and tolerability of the StimRouter Neuromodulation System, along with evaluating the technical performance of StimRouter, surgical outcomes, health-related quality of life, concomitant medical use, and subject's impression of improvement.

Conditions

  • Chronic Pain
  • Peripheral Neuropathy
  • Nervous System Diseases
  • Peripheral Nervous System Diseases
  • Peripheral Nervous System Problem
  • Peripheral Nerve Injuries
  • Peripheral Nervous

Interventions

  • StimRouter Neuromodulation SystemDevice

    An implantable neuromodulation device that treats chronic peripheral nerve pain.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Pain from Screening through 6 MonthsTime frame: Month 6

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • University of California San Diego

    La Jolla, California

  • California Orthopedics & Spine

    Larkspur, California

  • Stanford University

    Redwood City, California

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.